Pinnacle Associates LTD Macrogenics Inc Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Macrogenics Inc stock. As of the latest transaction made, Pinnacle Associates LTD holds 687,980 shares of MGNX stock, worth $2.24 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

687,980

Previous 637,319 7.95%

Holding current value

$2.24 Million

Previous $2.71 Million 16.43%

% of portfolio

0.04%

Previous 0.04%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$3.0 - $5.55 $151,983 - $281,168	50,661 Added 7.95%	687,980 $2.26 Million
Q2 2024 Jul 30, 2024	SELL	$3.31 - $18.51 $32,821 - $183,545	-9,916 Reduced 1.53%	637,319 $2.71 Million
Q1 2024 Apr 26, 2024	SELL	$9.77 - $21.47 $398,078 - $874,795	-40,745 Reduced 5.92%	647,235 $9.53 Million
Q4 2023 Jan 19, 2024	SELL	$4.48 - $10.11 $40,709 - $91,869	-9,087 Reduced 1.3%	687,980 $6.62 Million
Q3 2023 Oct 23, 2023	SELL	$4.48 - $6.19 $57,505 - $79,454	-12,836 Reduced 1.81%	697,067 $3.25 Million
Q2 2023 Jul 26, 2023	BUY	$4.62 - $7.54 $1.55 Million - $2.54 Million	336,430 Added 90.08%	709,903 $3.8 Million
Q1 2023 May 04, 2023	BUY	$4.82 - $7.24 $33,079 - $49,688	6,863 Added 1.87%	373,473 $2.68 Million
Q4 2022 Jan 31, 2023	SELL	$3.34 - $6.98 $2,999 - $6,268	-898 Reduced 0.24%	366,610 $2.46 Million
Q4 2022 Jan 25, 2023	SELL	$3.34 - $6.98 $167,066 - $349,139	-50,020 Reduced 11.98%	367,508 $0
Q3 2022 Oct 31, 2022	BUY	$3.01 - $5.22 $69,558 - $120,628	23,109 Added 5.86%	417,528 $1.45 Million
Q2 2022 Aug 02, 2022	SELL	$2.25 - $9.99 $20,693 - $91,878	-9,197 Reduced 2.28%	394,419 $1.16 Million
Q1 2022 May 05, 2022	SELL	$8.12 - $16.9 $119,972 - $249,697	-14,775 Reduced 3.53%	403,616 $3.56 Million
Q4 2021 Feb 02, 2022	BUY	$15.91 - $21.88 $29,163 - $40,106	1,833 Added 0.44%	418,391 $6.72 Million
Q3 2021 Oct 19, 2021	SELL	$19.74 - $28.7 $113,208 - $164,594	-5,735 Reduced 1.36%	416,558 $8.72 Million
Q2 2021 Aug 02, 2021	BUY	$20.49 - $35.63 $110,379 - $191,938	5,387 Added 1.29%	422,293 $11.3 Million
Q1 2021 May 12, 2021	BUY	$18.99 - $33.2 $1.43 Million - $2.49 Million	75,060 Added 21.96%	416,906 $13.3 Million
Q4 2020 Jan 26, 2021	SELL	$19.41 - $26.0 $1.66 Million - $2.22 Million	-85,550 Reduced 20.02%	341,846 $7.82 Million
Q3 2020 Oct 23, 2020	SELL	$24.69 - $31.6 $2.37 Million - $3.03 Million	-95,910 Reduced 18.33%	427,396 $10.8 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $1.24 Million - $6.96 Million	-239,064 Reduced 31.36%	523,306 $14.6 Million
Q1 2020 May 13, 2020	SELL	$4.28 - $12.11 $413,341 - $1.17 Million	-96,575 Reduced 11.24%	762,370 $4.44 Million
Q4 2019 Feb 03, 2020	BUY	$7.95 - $12.27 $2.44 Million - $3.77 Million	306,865 Added 55.58%	858,945 $9.35 Million
Q3 2019 Nov 08, 2019	SELL	$12.44 - $17.48 $303,349 - $426,249	-24,385 Reduced 4.23%	552,080 $7.05 Million
Q2 2019 Aug 05, 2019	SELL	$14.51 - $19.71 $706,390 - $959,541	-48,683 Reduced 7.79%	576,465 $9.78 Million
Q1 2019 May 10, 2019	BUY	$11.11 - $25.6 $965,681 - $2.23 Million	86,920 Added 16.15%	625,148 $11.2 Million
Q4 2018 Feb 05, 2019	SELL	$11.75 - $21.42 $658,799 - $1.2 Million	-56,068 Reduced 9.43%	538,228 $6.84 Million
Q3 2018 Nov 13, 2018	SELL	$19.26 - $23.46 $1.69 Million - $2.06 Million	-87,644 Reduced 12.85%	594,296 $12.7 Million
Q2 2018 Aug 08, 2018	SELL	$19.78 - $24.67 $2.14 Million - $2.67 Million	-108,160 Reduced 13.69%	681,940 $14.1 Million
Q1 2018 May 11, 2018	SELL	$18.89 - $32.46 $507,668 - $872,362	-26,875 Reduced 3.29%	790,100 $19.9 Million
Q4 2017 Feb 12, 2018	SELL	$16.19 - $20.3 $424,178 - $531,860	-26,200 Reduced 3.11%	816,975 $15.5 Million
Q3 2017 Nov 13, 2017	BUY	$15.52 - $18.94 $3.63 Million - $4.43 Million	233,657 Added 38.33%	843,175 $15.6 Million
Q2 2017 Aug 09, 2017	BUY	N/A	609,518	609,518 $10.7 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Macrogenics Inc Transaction History